Skincare Specimen file

La Roche-Posay Effaclar Duo Acne Treatment

A premium "derm" benzoyl-peroxide treatment recalled for benzene in 2025.

Recall · 2025 · resolved FDA benzoyl-peroxide benzene recall One of six BPO products voluntarily recalled at retail in March 2025 (lot MYX46W) after FDA testing found elevated benzene. Resolved. Source →

Our take

Why It’s on Our Radar

We don't recommend the recalled lot. A premium derm brand FDA-recalled for benzene: a cautionary listing showing the issue crosses price tiers.

What's inside

Ingredients & Safety

Benzoyl peroxide, which can degrade into benzene: the reason a specific lot was recalled.

Worth a closer look 1 ingredient we flag
Caution Benzoyl Peroxide 5.5% (sometimes listed as BPO) An acne active that can chemically break down into benzene, a known carcinogen, especially when stored warm: the basis of the 2024–2025 FDA testing and recalls.

Ingredient list reviewed

  • Benzoyl Peroxide 5.5%
  • Water also listed as Aqua, Purified Water
  • Glycerin also listed as Glycerine, Vegetable Glycerin
  • Silica also listed as Silica, E551
  • Dimethicone
  • Niacinamide

Formula scope: the disclosed ingredient list captured for this review. Formulas can differ by product, scent, country, and date; compare the current package with this list before deciding.

Want a cleaner option? Three Ships in Skincare currently meets our top criteria. Review its formula scope and cited records before deciding.

Who owns it

Ownership & Independence

La Roche-Posay is owned by L'Oréal.

Ownership record Acquired
Founded
1975
Headquarters
Clichy, France
Control
Owned by L'Oréal

Products covered

Key Products

We don't link to buy products we flag. Read why above, or see Three Ships, which meets our top criteria.

  • Effaclar Duo Dual Action Acne Treatment